Good EULAR Response In Patients With Early Rheumatoid Arthritis
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This open-label, prospective, observational study will evaluate the clinical response to
etanercept + methotrexate therapy in patients with moderate to severe rheumatoid arthritis,
as prescribed by the rheumatologist in a normal clinical setting in Greece